Senestech (SNES) Registration Filing summary

Company overview and business model

• Develops and commercializes fertility control products for managing rat and mouse populations, including ContraPest, Evolve Rat, and Evolve Mouse.

• ContraPest is a liquid bait targeting reproductive systems of rats, registered in all 50 states and major U.S. territories.

• Evolve Rat, launched in January 2024, is a soft bait using cottonseed oil, exempt from federal registration, and authorized in 48 states and two territories.

• Evolve Mouse, launched in May 2024, is authorized in 36 states and uses a similar formulation to Evolve Rat.

• Continuously enhances products and seeks regulatory approvals to expand market reach.

Financial performance and metrics

• Market value of outstanding common equity held by non-affiliates is $8,564,986.75 as of June 18, 2025.

• Sold $2,011,926.24 in securities in the prior 12 months under Form S-3 eligibility rules.

• Financial statements for 2024 and 2023 include a going concern warning due to net losses and capital deficiency.

Use of proceeds and capital allocation

• Net proceeds from offerings will be used for working capital and general corporate purposes, including R&D, capital expenditures, and administrative expenses.

• Management has broad discretion over use of proceeds; funds may be invested in short-term, investment-grade securities pending use.